The effect of technology implementation in providing drug information on consumer satisfaction in Jakarta, Indonesia
DOI:
https://doi.org/10.35814/jifi.v22i2.1598Keywords:
Consumer satisfaction, EUCS methods, post-pandemic, telemedicineAbstract
The provision of drug information (PDI) is a crucial factor influencing consumer behavior and ensuring appropriate drug use, thereby achieving therapeutic goals. With advancements in technology, digital platforms such as tele-counseling, WhatsApp, and social media are increasingly being used for PDI. However, challenges such as unclear communication, incomplete information, and delayed responses remain, which may affect consumer satisfaction. This study aims to assess consumer satisfaction with PDI through the implementation of a pharmacy application, using the End User Computing Satisfaction (EUCS) model, which evaluates information content, accuracy, format, ease of use, and timeliness. The research employed an associative, cross-sectional design and involved 250 consumers at Atma Jaya Pharmacy. Data were collected via a Likert-scale-based questionnaire, with responses analyzed to determine satisfaction levels in each EUCS dimension. Results showed that consumer satisfaction was consistently high across all dimensions, with the average satisfaction scores being 89.10% for information content, 90.19% for accuracy, 87.25% for format, 85.33% for ease of use, and 86.78% for timeliness. In conclusion, the use of technology in PDI significantly enhances consumer satisfaction, offering more accessible, accurate, and timely drug information. This study highlights the importance of optimizing technological tools in pharmaceutical services to improve user experience and satisfaction.
References
Downloads
Published
Issue
Section
License
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

















